SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001016504-03-000025
Filing Date
2003-11-06
Accepted
2003-11-06 14:18:09
Documents
6
Period of Report
2003-10-22
Items
Item 2: Acquisition or disposition of assets
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K OCTOBER 22, 2003 inb8koct22_2003.txt 8-K 5781
2 PRESS RELEASE FOR NOVEMBER 6, 2003 - EXHIBIT 99.1 exhibit99_1.txt EX-99 2093
3 REGISTRATION RIGHTS AGREEMENT - EXHIBIT 10.25 exhibit10_25.txt EX-10 17040
4 CONVERSION AND SUPPLY AGREEMENT - EXHIBIT 10.26 exhibit10_26.txt EX-10 41872
5 ESCROW AGREEMENT - EXHIBIT 2.7 exhibit2_7.txt EX-2 15696
6 ASSET PURCHASE AGREEMENT - EXHIBIT 2.6 exhibit2_6.txt EX-2 67166
  Complete submission text file 0001016504-03-000025.txt   152183
Mailing Address 201 ROUTE 22 HILLSIDE NJ 07205
Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 133035216 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31668 | Film No.: 03981933
SIC: 2834 Pharmaceutical Preparations